Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04868123 · ClinicalTrials.gov registry record · NA
Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy
A NA study of HIV Infections, sponsored by Rutgers University.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
- 2
- Study locations
NCT04868123: Completed NA study of HIV Infections, sponsored by Rutgers University.
NCT04868123 is a NA study of HIV Infections that has completed, run by Rutgers University. The registered enrollment target is 36 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04868123, a NA study of HIV Infections, has completed, sponsored by Rutgers University.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study is to explore the effects of transcutaneous nerve stimulation (TENS) and mindfulness meditation in persons living with HIV (PLHIV) and painful neuropathy in the feet.
Primary Outcome
Responses to questions on the Brief Pain Inventory Pain Intensity subscale used to generate pain intensity score. Minimum score=0; maximum score=10; higher score=worse outcome. Thus if change is a negative value, that indicates improvement. If the change is a positive value, that indicates worsening.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness Meditation
- DEVICE Transcutaneous Nerve Stimulation (TENS)
Study Locations (2)
New Jersey
- Rutgers Physical Therapy Program - Blackwood
- Rutgers Physical Therapy Program - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2022-04-22 |
| Est. Completion | 2025-01-07 |
| Phase | NA |
What the finished NCT04868123 record still lists
NCT04868123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (92% lower).
The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness Meditation is the first listed.
NCT04868123 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT04868123 about?
NCT04868123 is a clinical study titled "Effects of TENS and Mindfulness Meditation in Persons With HIV-related Neuropathy". This study is to explore the effects of transcutaneous nerve stimulation (TENS) and mindfulness meditation in persons living with HIV (PLHIV) and painful neuropathy in the feet.
What is the current status of trial NCT04868123?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2022-04-22. Estimated completion is 2025-01-07.
What conditions does trial NCT04868123 study?
This clinical trial studies the following conditions: HIV Infections.
What interventions are being tested in trial NCT04868123?
The interventions under investigation include: Mindfulness Meditation (BEHAVIORAL), Transcutaneous Nerve Stimulation (TENS) (DEVICE).
Who is sponsoring clinical trial NCT04868123?
This trial is sponsored by Rutgers University, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04868123 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04868123's enrollment target sits among peer trials
36 406th of 542 higher than 131 of 542 other HIV Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI